Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineered bio-nanocapsules, the selective vector for drug delivery system.

Dongwei Yu1, Takayuki Fukuda, Tuoya

  • 1Graduate School of Natural Science and Technology, Okayama University, 3.1.1 Tsushima-Naka, Okayama 700-8530, Japan.

IUBMB Life
|April 7, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Factors of Cardiopulmonary Arrest Patients by a Physician-Staffed Helicopter.

Air medical journal·2018
Same author

Widespread effect of N-acetyl-D-glucosamine assimilation on the metabolisms of amino acids, purines, and pyrimidines in Scheffersomyces stipitis.

Microbial cell factories·2018
Same author

Herbicide tolerance-assisted multiplex targeted nucleotide substitution in rice.

Data in brief·2018
Same author

Development of a strictly regulated xylose-induced expression system in Streptomyces.

Microbial cell factories·2018
Same author

A Case of Near-Fatal Drowning Caused by an Attack from a Wild Boar.

Wilderness & environmental medicine·2018
Same author

De novo design of biosynthetic pathways for bacterial production of bulk chemicals and biofuels.

FEMS microbiology letters·2018

Engineered bio-nanocapsules (BNCs), derived from hepatitis B virus proteins, show potential for targeted drug delivery. These artificial nanoparticles offer selective delivery capabilities for novel therapeutic applications.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Virology

Background:

  • Bio-nanocapsules (BNCs) are artificial hollow nanoparticles created using biotechnological methods.
  • An engineered BNC utilizes a recombinant L envelope protein of the hepatitis B virus (HBV) and host-derived lipids.
  • Initially designed as a hepatitis B vaccine immunogen, its properties were further explored.

Purpose of the Study:

  • To introduce the concept and development of bio-nanocapsules (BNCs).
  • To highlight the potential of BNCs as a drug delivery system (DDS) vector.
  • To leverage the hepatocyte-specific infectivity conferred by the HBV L envelope protein's pre-S1 region.

Main Methods:

  • Design and production of hollow nanoparticles using biotechnological procedures.

Related Experiment Videos

  • Construction of BNCs using recombinant HBV L envelope protein and host cell lipids.
  • Characterization of BNCs for their structural and functional properties.

    • Main Results:

    • The engineered BNC successfully incorporates the recombinant HBV L envelope protein and host lipids.
    • The pre-S1 region of the L envelope protein imparts specific infectivity for hepatocytes.
    • The BNC demonstrates potential as a platform for targeted drug delivery.

    Conclusions:

    • Bio-nanocapsules represent a novel class of engineered nanoparticles.
    • The HBV-derived BNC shows promise as a selective drug delivery vector.
    • Further development of BNCs could lead to advanced therapeutic strategies.